<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mosley, Mary</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Libby, Peter</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Impact of Abdominal Obesity on CVD and Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">Obesity is an inflammatory process, and as visceral adipose tissue (VAT) increases, inflammation increases. As the components of metabolic syndrome increase, inflammation increases, as shown by increases in C-reactive protein (CRP) in the Women's Health Study [Ridker PM et al. Circulation 2003]. Additionally, this article discusses the role of epicardial and intrathoracic fat with cardiovascular (CV) risk factors, and the association between low levels of high-density lipoprotein cholesterol (HDL-C; &lt;60 mg/dL) and increased hazard of coronary heart disease, stroke, and CV events.</style></abstract><number><style face="normal" font="default" size="100%">16</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>